Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
about
Adjunctive antioxidants for bipolar disorderValproic acid, valproate and divalproex in the maintenance treatment of bipolar disorderPrevalence and clinical features associated with bipolar disorder polypharmacy: a systematic reviewManagement of bipolar depression with lamotrigine: an antiepileptic mood stabilizerGuideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012Emotional dysfunction as a marker of bipolar disordersCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmThe International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelinesNoradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episodeThe association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (TriaAripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literatureLithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patientsEffect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleusMono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSPProtocol: Adaptive Implementation of Effective Programs Trial (ADEPT): cluster randomized SMART trial comparing a standard versus enhanced implementation strategy to improve outcomes of a mood disorders programRelationship between frontostriatal morphology and executive function deficits in bipolar I disorder following a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).Neurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)Treatment of bipolar disorder with comorbid migraine.Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients.Towards the clinical implementation of pharmacogenetics in bipolar disorder.Case report on the management of depression in schizoaffective disorder, bipolar type focusing on lithium levels and measurement-based care.Asenapine: a review of acute and extension phase data in bipolar disorder.Role of extended release quetiapine in the management of bipolar disorders.The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic studyPragmatic randomised controlled trial of group psychoeducation versus group support in the maintenance of bipolar disorder.Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.Antidepressants for bipolar disorder: A meta-analysis of randomized, double-blind, controlled trials.Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder.Antidepressant treatment for acute bipolar depression: an update.Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.Valproate in acute mania: is our practice evidence based?Maintenance therapies in bipolar disorders.Evidence-based options for treatment-resistant adult bipolar disorder patients.Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.Mania: diagnosis and treatment recommendations.Combination therapy for manic phases: a critical review of a common practice.Potential mechanisms of action of lithium in bipolar disorder. Current understanding.High-dose prazosin for the treatment of post-traumatic stress disorder.
P2860
Q24198987-B49C6648-2489-4F90-B01F-95CB71E338D9Q24203023-F9551AF5-883A-4813-8E99-DAE4F8AE7BF5Q26751363-7BC6E400-C299-470D-8E0C-37C66C561B92Q26777966-ED63B278-7509-4246-A75F-1537AAA3910BQ26824955-DF292578-C073-4F36-9881-05EBD22447A2Q27009019-0670E2FF-F90A-48D7-BD11-CC820D85E6D6Q27009995-2E60B4E4-BE08-44FC-A53D-41B4584E63E6Q28066714-C73AC6E2-5A0C-4994-A426-FD0787319377Q28069743-B31AEDE1-C92D-4B48-AE73-07F26E542042Q28076943-7225865F-6295-48F0-AA75-7389127CD6EAQ28281197-4E149E6F-DCDE-4556-A21C-89C9FD526650Q28478032-14124819-0366-4B9B-836E-4D3D254E74E3Q28478124-8FC4A197-333B-4689-936F-B48B5B57BAB6Q28564629-CC82BDBA-D029-405A-A5EA-FEF036AD4108Q30569917-375735AA-DE33-4D7D-803C-B95265588057Q30590222-2A883BE4-E747-4E50-BE6E-A5997DF971A8Q30659584-63246ADB-829C-4BFC-B1DF-E5CAB6AC5FDBQ30897232-CB4891BE-F703-49C8-BEBC-1BE821A80E9FQ33563182-EEF18647-C616-4A90-B6B8-AF45F3DAFDBAQ33573950-7149D499-A8E4-4D64-8D4E-8DC763A1DEDDQ33688133-3317FFD4-8F96-484D-8E26-65CDCE1CFCBFQ33718907-043726B2-35DF-4F54-AC47-685B6740DE30Q33719794-36642F92-AEF3-4627-9733-6460E8AB9F21Q33755661-4512282F-75A0-4281-8DD6-0A84D58E3C85Q33817419-8BDD9B91-5632-425A-98C9-AD02C2CCC0F3Q33967329-1939E563-CFB4-4162-968E-A53CE214355EQ34068878-1F3418F5-6629-4B5C-BCD6-BDD4BC8097D3Q34095729-66BDC1F7-1C79-4752-9AD8-DE9E8F056B5AQ34148283-26AD155B-9196-4141-ABF5-B4202E5C6D95Q34154885-44EC8C26-D93B-47F3-A8F8-B75404DB7BE9Q34197988-C632C24E-4138-4CC2-BD41-6A9922335974Q34218568-5BFED2F4-352A-46AD-BEE4-A45772F33CE8Q34264093-F20C3B6A-0787-4660-8381-5734C812C015Q34268760-33E512D4-998C-4D6C-949F-FD227973AF8FQ34296938-4463F4E7-EB45-4FE4-8D53-40E0ED6D67D1Q34297422-5B87D8D9-8D6E-4350-897D-6D2E23D193F4Q34300315-F82DCA38-B005-4B4A-A518-AD80006B680FQ34308027-92C97EB0-B582-4B8E-8929-A92D6F7957E6Q34325612-D35C5371-A338-4F83-9A17-C5B1A921EF33Q34401780-0317A1D4-774A-4F9D-B41C-5AE42BD8AA51
P2860
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Canadian Network for Mood and ...... bipolar disorder: update 2009.
@en
type
label
Canadian Network for Mood and ...... bipolar disorder: update 2009.
@en
prefLabel
Canadian Network for Mood and ...... bipolar disorder: update 2009.
@en
P2093
P2860
P50
P921
P1433
P1476
Canadian Network for Mood and ...... bipolar disorder: update 2009.
@en
P2093
Allan H Young
Arun Ravindran
Ayal Schaffer
Claire O'Donovan
Glenda MacQueen
Joseph R Calabrese
Kyooseob Ha
L Trevor Young
Lakshmi N Yatham
Martin Alda
P2860
P304
P356
10.1111/J.1399-5618.2009.00672.X
P577
2009-05-01T00:00:00Z